SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-021114
Filing Date
2021-05-28
Accepted
2021-05-28 16:47:00
Documents
2
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1615
2 EX-24 DOCUMENT attachment1.htm EX-24 4662
  Complete submission text file 0000899243-21-021114.txt   7796
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BLVD., SUITE 260 NEWPORT BEACH CA 92660
Business Address
Akamine Scott (Reporting) CIK: 0001816720 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39311 | Film No.: 21981121